Abstract
Chryseobacterium species are a rare cause of human disease and are usually associated with indwelling devices or altered immune status. This is the first case to our knowledge, of Chryseobacterium indologenes bacteremia in a previously healthy infant. Chryseobacteria are pathogens resistant to the usual empiric treatments for neonatal or infantile septicemia.
Copyright 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Bacteremia / diagnosis*
-
Bacteremia / drug therapy
-
Bacteremia / microbiology*
-
Cefepime
-
Cephalosporins / therapeutic use
-
Chryseobacterium / drug effects
-
Chryseobacterium / isolation & purification*
-
Female
-
Flavobacteriaceae Infections / diagnosis*
-
Flavobacteriaceae Infections / drug therapy
-
Flavobacteriaceae Infections / microbiology*
-
Humans
-
Infant
-
Microbial Sensitivity Tests
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Cephalosporins
-
Cefepime